NZ329311A - use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus - Google Patents
use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virusInfo
- Publication number
- NZ329311A NZ329311A NZ329311A NZ32931195A NZ329311A NZ 329311 A NZ329311 A NZ 329311A NZ 329311 A NZ329311 A NZ 329311A NZ 32931195 A NZ32931195 A NZ 32931195A NZ 329311 A NZ329311 A NZ 329311A
- Authority
- NZ
- New Zealand
- Prior art keywords
- human milk
- casein
- mammalian cells
- contained
- infection
- Prior art date
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title abstract 5
- 208000015181 infectious disease Diseases 0.000 title abstract 4
- 210000004962 mammalian cell Anatomy 0.000 title abstract 4
- 102000011632 Caseins Human genes 0.000 title 1
- 108010076119 Caseins Proteins 0.000 title 1
- 235000021247 β-casein Nutrition 0.000 title 1
- 210000004251 human milk Anatomy 0.000 abstract 8
- 235000020256 human milk Nutrition 0.000 abstract 8
- 239000005018 casein Substances 0.000 abstract 6
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 3
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a medicament for inhibiting the infection of mammalian cells by RSV (Respiratory Syncytial Virus). b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a liquid nutritional product or an infant formula also containing at least one protein not contained in human milk for inhibiting the infection of mammalian cells by RSV. b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a enteral nutritional product also containing at least one protein not contained in human milk for treating and/or preventing respiratory tract infection in a mammal by inhibiting the infection of mammalian cells by RSV.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/249,555 US5538952A (en) | 1994-05-26 | 1994-05-26 | Inhibition of infection of mammalian cells by respiratory syncytial virus |
| US08/249,554 US5506209A (en) | 1994-05-26 | 1994-05-26 | Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
| NZ283578A NZ283578A (en) | 1994-05-26 | 1995-03-27 | Nutritional product containing beta casein effective in preventing infection of human cells by respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ329311A true NZ329311A (en) | 2000-07-28 |
Family
ID=27353772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ329311A NZ329311A (en) | 1994-05-26 | 1995-03-27 | use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ329311A (en) |
-
1995
- 1995-03-27 NZ NZ329311A patent/NZ329311A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9401406D0 (en) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| NZ215939A (en) | Phosphonyl methoxyadenine antiviral compositions | |
| SE9600233L (en) | Use of a lactoperoxidase system for the preparation of a drug against Helicobacter pylori | |
| CA2054358A1 (en) | High acid nutritional formulations | |
| DK0913156T3 (en) | Use of activated protein C for the treatment of hypercoagulation conditions associated with sepsis | |
| HU912064D0 (en) | Process for the production of aralyphic n-substituted amino-alcane-phosphine acids and medical preparations containing them | |
| ZA888461B (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
| PT914110E (en) | METHOD OF MODULATING MICRO-CIRCULATION | |
| FI940659A0 (en) | Heterocyclic-substituted phenylcyclohexanecarboxylic acid derivatives | |
| HU910979D0 (en) | Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives | |
| ATE78696T1 (en) | MEDICINAL PREPARATION FOR THE TREATMENT OF IMMUNE DEFICIENCY. | |
| EP0451750A3 (en) | Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients | |
| US5543392A (en) | Digestive tract cell activating agent of EGF and lactoferrin | |
| NZ329311A (en) | use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus | |
| ATE143947T1 (en) | N-ACYLPYRROLIDINE AND MEDICINAL PRODUCTS FOR THE TREATMENT OR PROPHYLAXIS OF CKK AND GASTRINE-RELATED DISEASES | |
| IL102774A0 (en) | Process for the preparation of human protein-containing,readily compatible medicaments for infusion or injection purposes | |
| MX9803565A (en) | A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein. | |
| MX9605830A (en) | Inhibition of infection of mammalian cells by respiratory syncytial virus. | |
| Franks | A randomized trial of amniotomy in active labor | |
| JPS649938A (en) | Oral ingestive composition | |
| AU1158197A (en) | Product for inhibition of attachment of h. influenzae to human cells | |
| MX9605829A (en) | Inhibition of attachment of h. influenzae to human cells. | |
| MX9701979A (en) | Inhibition of human rotavirus infection. | |
| DE3476736D1 (en) | Use of an antihypoxidoticum with cerebral and peripheral effect | |
| Ichikawa | Protection of the surgical wound following plastic surgery and nursing care to maintain cleanliness of the regions--protection and preservation of the surgical wound following plastic surgery of cleft lip and palate and microtia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |